ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/12/08 | 3,000 | 3,195 | 2,990 | 3,145 | +90 | +2.9% | 2,021,500 |
2023/12/07 | 3,270 | 3,320 | 3,050 | 3,055 | -160 | -5% | 2,842,000 |
2023/12/06 | 3,075 | 3,275 | 2,800 | 3,215 | +170 | +5.6% | 6,552,100 |
2023/12/05 | 3,075 | 3,155 | 2,994 | 3,045 | -170 | -5.3% | 3,270,400 |
2023/12/04 | 2,980 | 3,250 | 2,980 | 3,215 | +95 | +3% | 2,090,700 |
2023/12/01 | 3,190 | 3,220 | 3,025 | 3,120 | -260 | -7.7% | 3,892,400 |
2023/11/30 | 3,555 | 3,555 | 3,320 | 3,380 | -45 | -1.3% | 4,299,800 |
2023/11/29 | 3,150 | 3,465 | 3,145 | 3,425 | +325 | +10.5% | 5,602,800 |
2023/11/28 | 3,055 | 3,135 | 3,020 | 3,100 | +40 | +1.3% | 2,196,600 |
2023/11/27 | 3,105 | 3,165 | 2,999 | 3,060 | -10 | -0.3% | 4,432,100 |
2023/11/24 | 2,921 | 3,100 | 2,921 | 3,070 | +166 | +5.7% | 5,578,400 |
2023/11/22 | 2,825 | 2,969 | 2,747 | 2,904 | -21 | -0.7% | 12,793,200 |
2023/11/21 | 2,930 | 3,030 | 2,820 | 2,925 | +74 | +2.6% | 13,751,600 |
2023/11/20 | 2,761 | 2,908 | 2,732 | 2,851 | +53 | +1.9% | 14,112,900 |
2023/11/17 | 2,551 | 2,875 | 2,520 | 2,798 | +297 | +11.9% | 21,592,000 |
2023/11/16 | 2,262 | 2,512 | 2,260 | 2,501 | +289 | +13.1% | 14,148,600 |
2023/11/15 | 1,939 | 2,282 | 1,937 | 2,212 | +312 | +16.4% | 10,446,600 |
2023/11/14 | 1,956 | 1,956 | 1,888 | 1,900 | -29 | -1.5% | 1,147,400 |
2023/11/13 | 1,954 | 1,975 | 1,914 | 1,929 | -16 | -0.8% | 1,367,600 |
2023/11/10 | 1,983 | 1,986 | 1,930 | 1,945 | -79 | -3.9% | 1,818,100 |
2023/11/09 | 2,038 | 2,039 | 1,971 | 2,024 | -6 | -0.3% | 1,561,900 |
2023/11/08 | 2,091 | 2,124 | 2,016 | 2,030 | -20 | -1% | 2,414,000 |
2023/11/07 | 2,066 | 2,089 | 2,026 | 2,050 | -7 | -0.3% | 2,303,900 |
2023/11/06 | 1,992 | 2,107 | 1,973 | 2,057 | +97 | +4.9% | 3,168,100 |
2023/11/02 | 1,940 | 1,987 | 1,918 | 1,960 | +28 | +1.4% | 1,769,300 |
2023/11/01 | 1,987 | 1,988 | 1,877 | 1,932 | -55 | -2.8% | 2,528,300 |
2023/10/31 | 1,970 | 2,015 | 1,944 | 1,987 | +17 | +0.9% | 2,050,100 |
2023/10/30 | 1,948 | 1,993 | 1,930 | 1,970 | +20 | +1% | 1,908,400 |
2023/10/27 | 1,850 | 1,950 | 1,821 | 1,950 | +82 | +4.4% | 2,778,600 |
2023/10/26 | 1,777 | 1,923 | 1,770 | 1,868 | +66 | +3.7% | 3,780,600 |
2023/10/25 | 1,820 | 1,848 | 1,760 | 1,802 | +6 | +0.3% | 2,372,700 |
2023/10/24 | 1,952 | 2,012 | 1,661 | 1,796 | -184 | -9.3% | 6,879,800 |
2023/10/23 | 2,100 | 2,119 | 1,866 | 1,980 | +91 | +4.8% | 7,166,800 |
2023/10/20 | 1,866 | 1,920 | 1,835 | 1,889 | -17 | -0.9% | 1,561,400 |
2023/10/19 | 1,920 | 1,942 | 1,876 | 1,906 | -50 | -2.6% | 1,765,500 |
2023/10/18 | 1,961 | 2,004 | 1,927 | 1,956 | -6 | -0.3% | 2,058,200 |
2023/10/17 | 1,958 | 1,976 | 1,893 | 1,962 | +111 | +6% | 2,582,400 |
2023/10/16 | 2,061 | 2,064 | 1,838 | 1,851 | -278 | -13.1% | 4,440,700 |
2023/10/13 | 2,164 | 2,181 | 2,113 | 2,129 | -34 | -1.6% | 2,030,500 |
2023/10/12 | 2,236 | 2,236 | 2,151 | 2,163 | -47 | -2.1% | 1,987,000 |
2023/10/11 | 2,224 | 2,298 | 2,208 | 2,210 | +7 | +0.3% | 3,156,900 |
2023/10/10 | 2,098 | 2,229 | 2,075 | 2,203 | +133 | +6.4% | 3,088,300 |
2023/10/06 | 2,033 | 2,079 | 1,978 | 2,070 | +52 | +2.6% | 2,286,100 |
2023/10/05 | 2,025 | 2,043 | 1,973 | 2,018 | +1 | ±0% | 2,292,900 |
2023/10/04 | 2,019 | 2,063 | 1,992 | 2,017 | -44 | -2.1% | 2,798,300 |
2023/10/03 | 2,011 | 2,072 | 1,947 | 2,061 | +37 | +1.8% | 3,004,100 |
2023/10/02 | 2,049 | 2,092 | 2,021 | 2,024 | -14 | -0.7% | 3,157,600 |
2023/09/29 | 2,009 | 2,073 | 2,009 | 2,038 | +46 | +2.3% | 2,921,000 |
2023/09/28 | 1,999 | 2,009 | 1,946 | 1,992 | +2 | +0.1% | 1,977,100 |
2023/09/27 | 1,934 | 2,000 | 1,922 | 1,990 | +40 | +2.1% | 2,340,900 |
101~
150
件表示中 / 3452件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 241,700円 | +52.1% | +23.3% | 0.00% | 17.08倍 | 3.57倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
ネクセラファーマ | 149,600円 | +150.7% | - | 0.00% | 38.23倍 | 2.00倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 323,000円 | -1.2% | -37.3% | 2.48% | 26.03倍 | 0.90倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 182,900円 | +2.6% | +11.5% | 2.84% | 21.44倍 | 0.83倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
鳥居薬 | 401,500円 | +7.3% | +16.8% | 2.99% | 24.01倍 | 0.94倍 |
|
JT傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗HIV薬の販売権喪失が直撃 |
市場注目の銘柄
チャート関連のコラム